Literature DB >> 9482574

Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours.

T F Homfray1, S E Cottrell, M Ilyas, A Rowan, I C Talbot, W F Bodmer, I P Tomlinson.   

Abstract

The roles of the intrinsic mutation rate and genomic instability in tumorigenesis are currently controversial. In most colorectal tumours, it is generally supposed that the first mutations occur at the adenomatous polyposis coli (APC) locus; APC mutations are thought to provide cells with a selective advantage but have no known effect on the mutation rate. It has also been suggested that genomic instability is the initiating event in colorectal tumorigenesis and, if this is true, mutations of DNA mismatch repair (MMR) genes (or at similar loci) are the most likely candidates. If defective MMR precedes APC mutations, the APC mutations of colon tumours with defective MMR and hence replication errors (RER+) should differ from those of RER- tumours, in at least three specific ways: (1) a higher frequency of allele loss at APC in RER- tumours; (2) more frameshift than nonsense mutations in RER+ tumours; and (3) APC mutations in simple repeat sequences [(N)n, (N1N2)n, or (N1N2N3)n] in RER+ tumours. We found no evidence that sporadic RER+ and RER- colon cancers (including cell lines) differ in any of these three ways. Although it remains possible that MMR is abnormal in tumours from HNPCC families before APC mutations occur, it is likely that in sporadic colon tumours, APC mutations, rather than genomic instability, are the initiating events in tumorigenesis.

Entities:  

Mesh:

Year:  1998        PMID: 9482574     DOI: 10.1002/(SICI)1098-1004(1998)11:2<114::AID-HUMU3>3.0.CO;2-J

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  19 in total

1.  Mismatch repair processing of carcinogen-DNA adducts triggers apoptosis.

Authors:  J Wu; L Gu; H Wang; N E Geacintov; G M Li
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

Review 2.  DNA mismatch repair genes and colorectal cancer.

Authors:  J M Wheeler; W F Bodmer; N J Mortensen
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

3.  Proximal and progressive: adenomas in HNPCC.

Authors:  D T Bishop
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

4.  Crypt dynamics and colorectal cancer: advances in mathematical modelling.

Authors:  I M M van Leeuwen; H M Byrne; O E Jensen; J R King
Journal:  Cell Prolif       Date:  2006-06       Impact factor: 6.831

5.  APC mutations are sufficient for the growth of early colorectal adenomas.

Authors:  H Lamlum; A Papadopoulou; M Ilyas; A Rowan; C Gillet; A Hanby; I Talbot; W Bodmer; I Tomlinson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

6.  Aneuploid colon cancer cells have a robust spindle checkpoint.

Authors:  A Tighe; V L Johnson; M Albertella; S S Taylor
Journal:  EMBO Rep       Date:  2001-07-03       Impact factor: 8.807

7.  The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers.

Authors:  J M Wheeler; A Loukola; L A Aaltonen; N J Mortensen; W F Bodmer
Journal:  J Med Genet       Date:  2000-08       Impact factor: 6.318

8.  Genetic pathways of colorectal carcinogenesis rarely involve the PTEN and LKB1 genes outside the inherited hamartoma syndromes.

Authors:  Z J Wang; F Taylor; M Churchman; G Norbury; I Tomlinson
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

9.  CD4+ lymphocytes modulate prostate cancer progression in mice.

Authors:  Theofilos Poutahidis; Varada P Rao; Werner Olipitz; Christie L Taylor; Erin A Jackson; Tatiana Levkovich; Chung Wei Lee; James G Fox; Zhongming Ge; Susan E Erdman
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

Review 10.  Genetic instability is not a requirement for tumor development.

Authors:  Walter Bodmer; Jason H Bielas; Robert A Beckman
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.